Search For "ph"
Uttarakhand to have single-phase election on February 14
Updated : 4 years, 2 months ago IST
New Delhi [India], January 8 (ANI): Uttarakhand will for go for a single-phase assembly polls on February 14.
Read More
Voting for Punjab, Uttarakhand, Goa assembly elections to be held in singl
Updated : 4 years, 2 months ago IST
New Delhi [India], January 8 (ANI): Voting for Punjab, Uttarakhand and Goa assembly elections will be held in a single phase on February 14, the Election Commission said on Saturday.
Read More
EC announces seven-phase assembly poll in Uttar Pradesh from Feb 10 to Mar
Updated : 4 years, 2 months ago IST
New Delhi [India], January 8 (ANI): The Election Commission of India (ECI) on Saturday announced seven-phase election to Uttar Pradesh assembly from February 10 to March 7.
Read More
Signity Pharmaceuticals bags title of 'The Fastest Growing Pharmaceutical
Updated : 4 years, 2 months ago IST
New Delhi [India], January 7 (ANI/TPT): Signity Pharmaceuticals Pvt. Ltd., an upcoming super-specialty company, has been honoured with the title of "The Fastest Growing Pharmaceutical Company of Central India" at the International Business Leadership Awards 2021.
Read More
CCEA approves scheme on green energy corridor phase-II for intra-state tra
Updated : 4 years, 2 months ago IST
New Delhi [India], January 6 (ANI): The Cabinet Committee on Economic Affairs on Thursday approved a scheme on Green Energy Corridor (GEC) Phase-II for Intra-State Transmission System (InSTS) which will help in achieving the target of 450 GW installed renewal energy capacity by 2030.
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
A step towards Anemia Mukt Bharat
Updated : 4 years, 2 months ago IST
New Delhi [India], January 3 (ANI/GIPR): Dr Satya Vadlamani's contribution towards the building of the nation is immense, as apparent in the past more than two decades, which she has dedicated to bringing smiles to innumerable faces.
Read More
Official announcement of Associate Partners for Dadasaheb Phalke Internati
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 3 (ANI/Target Media): India's most prestigious award ceremony is right around the corner, celebrating the indelible mark of the entertainment industry and lauding stellar cultural performances.
Read More
Navjot Sidhu hits out at Centre over 'skyrocketing' fuel prices
Updated : 4 years, 2 months ago IST
Phagwara (Punjab) [India], January 3 (ANI): Punjab Pradesh Congress Committee President Navjot Singh Sidhu has hit out at the Centre over "skyrocketing prices" of fuel prices and said that the inflation has been unjustified and unfair to its people causing distress to the people.
Read More
Study finds heavy hydrogen stabilizes drugs
Updated : 4 years, 2 months ago IST
Bonn [Germany], January 2 (ANI): A team of researchers have found a method that allows the heavier hydrogen 'brother' deuterium to be introduced specifically into many different molecules. Drugs produced using this method can be effective for longer and be taken in lower doses or less freque
Read More
CBI conducts raids at 12 locations of pharmaceutical company in Chandigarh
Updated : 4 years, 2 months ago IST
New Delhi [India], December 31 (ANI): The Central Bureau of Investigation (CBI) on Friday registered a case against a pharmaceutical company and conducted a search in premises of its Directors on the allegations of bank fraud of Rs 1600 crore.
Read More
Covaxin found to be safe, immunogenic in 2-18 age group in phase 2, 3 stud
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.
Read More